Juan Bascuas

Tolerability and Reactogenicity Profile of mRNA SARS-Cov-2 Vaccines from a Mass Vaccination Campaign in a Tertiary Hospital: Between-Vaccine and Between-Population Prospective Observational Study (VigilVacCOVID Study)

J. Bartra, Cristina Carrera, Sara Gómez, 2022, BioDrugs.